Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052451/0903 | |
| Pages: | 2 |
| | Recorded: | 04/21/2020 | | |
| Attorney Dkt #: | NACU:1020 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/26/2023
|
Application #:
|
16738819
|
Filing Dt:
|
01/09/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/16/2020
| | | | |
|
Title:
|
Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide)(DiNACA)
|
|
|
Assignee
|
|
|
|
|
| 306 W. 7TH STREET, SUITE 310 |
| FORT WORTH CLUB BUILDING |
| FORT WORTH, TEXAS 76109 |
|
|
Correspondence name and address
|
| |
CHALKER FLORES, LLP
|
| |
14951 NORTH DALLAS PARKWAY, SUITE 400
|
| |
DALLAS, TX 75254
|
Search Results as of:
06/16/2024 03:01 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
